Clinical trial
Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules
NCT07773064 is registered in ClinicalTrials.gov with Beijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules
- Lead sponsor
- Beijing Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 14, 2024
- Completion date
- December 31, 2027
- Enrollment
- 3,000 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.